Related Experiment Video
Updated: Aug 11, 2026
Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer
Published on: February 12, 2022
[Modified radical vulvectomy--a reasonable alternative in the treatment of T1-T2 squamous cell vulvar carcinoma]
Aim:
To review our experience in the treatment of vulvar cancer by modified radical vulvectomy (MRV) in a selected group of patients.
Methods:
In a retrospective analysis of a 5-year period, we studied 8 patients with vulvar cancer who underwent MRV, and diagnosed with early T1-T2 cancer. The primary tumor and groin lymph nodes were submitted to radical surgery, applying individual approach to each patient.
Results:
In all patients, both operative and postoperative periods were uneventful and shorter as compared to patients in whom traditional approaches were used. Operative wounds healed by first intention. Until now, we have found only one local recurrence and the patient was successfully re-operated on. In all women treated by MRV we had a good cosmetic effect, as compared with patients who underwent radical vulvectomy, en-bloc resection or reconstructive surgery.
Conclusions:
MRV can be applied as a method of choice in selected patients with early vulvar cancer.
